Division for Health Technology Evaluation Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
Department of Nursing Science, College of Nursing, Gachon University, Incheon, Korea.
Prostate Cancer Prostatic Dis. 2019 Sep;22(3):461-466. doi: 10.1038/s41391-018-0119-9. Epub 2019 Jan 24.
This study presented the utility across approaches (robotic-assisted radical prostatectomy (RARP) and laparoscopic radical prostatectomy (LRP) or open radical prostatectomy (ORP)), across disease states after surgery, and also across functional outcomes for localized prostate cancers. The utility was measured using the time trade-off method.
This survey was based on a scenario that describes the state of health in detail and considers surgical methods, short-term adverse effects following RP, disease-specific conditions, and additional treatments 1 year following RP.
This study analyzed 393 men; the utility values are as follows: first, health status postoperatively showed that the utility value decreased in patients who underwent ORP versus those who underwent LRP. The utility value for ORP and LRP versus RARP was reduced by ~0.028 (10 days per year) and 0.008 (3 days per year), respectively. Second, the utility value based on adverse effects after RP indicated that erectile dysfunction caused a greater reduction in efficacy than urinary incontinence. Regarding erectile dysfunction and urinary incontinence, the efficacy was reduced to ~0.137 (50 days per year) and 0.111 (41 days per year), respectively, as compared to a health state without adverse effects based on no evidence of disease status.
In conclusion, the disutility was much greater due to the side effects than the disutility due to the difference in the surgical method. In particular, the disutility of erectile dysfunction was bigger than that of the urinary incontinence.
本研究展示了在不同方法(机器人辅助根治性前列腺切除术(RARP)和腹腔镜根治性前列腺切除术(LRP)或开放性根治性前列腺切除术(ORP))、手术后不同疾病状态以及局限性前列腺癌的不同功能结局方面的效用。使用时间权衡法测量了效用。
本调查基于详细描述健康状况的情况,并考虑了 RP 后的手术方法、短期不良影响、疾病特异性情况以及 RP 后 1 年的其他治疗方法。
本研究分析了 393 名男性;效用值如下:首先,术后健康状况显示,接受 ORP 的患者与接受 LRP 的患者相比,效用值降低。与 RARP 相比,ORP 和 LRP 的效用值分别降低了约 0.028(每年 10 天)和 0.008(每年 3 天)。其次,基于 RP 后不良反应的效用值表明,勃起功能障碍导致的疗效降低大于尿失禁。关于勃起功能障碍和尿失禁,与无疾病状态下无不良反应的健康状态相比,疗效分别降低了约 0.137(每年 50 天)和 0.111(每年 41 天)。
总之,由于副作用导致的不效用大于由于手术方法不同导致的不效用。特别是,勃起功能障碍的不效用大于尿失禁的不效用。